Podcasts

AUDIO: Conjugated estrogen, bazedoxifene combo offers menopause treatment option


 

EXPERT ANALYSIS FROM THE NAMS ANNUAL MEETING

References

NATIONAL HARBOR, MD. – Treating menopause symptoms in women who still have a uterus can be difficult, but alternatives to estrogen are available.

For many women, the use of estrogen therapies is contraindicated – and even if it is prescribed, many women are noncompliant because of fears of increased risk of breast or uterine cancer, explained Dr. JoAnn Pinkerton of the University of Virginia, Charlottesville.

However, with the U.S. Food and Drug Administration’s recent approval of Duavee, a combination of conjugated estrogen and bazedoxifene, Dr. Pinkerton noted, women who don’t want to take estrogen have another option for quelling their menopause symptoms.

In an interview at the annual meeting of the North American Menopause Society, Dr. Pinkerton analyzes the benefits of combination therapy.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

USPSTF: Offer behavioral counseling to prevent cardiovascular disease
MDedge ObGyn
Estrogen-containing OCs cloud measurement of ovarian reserve
MDedge ObGyn
Gestational diabetes may increase child’s risk of glucose intolerance
MDedge ObGyn
After 3-year stumble, new weight-loss drug wins FDA approval
MDedge ObGyn
UTIs in type 2 diabetes can be costly
MDedge ObGyn
Autism risks increase after in utero antidiabetic medication exposure
MDedge ObGyn
Gout may predispose people, particularly women, to diabetes
MDedge ObGyn
Eating fried food before pregnancy may increase risk of gestational diabetes
MDedge ObGyn
Retinopathy screening during gestational diabetes may be lacking
MDedge ObGyn
VIDEO: Is the FDA’s black box on estrogen too ‘alarming’?
MDedge ObGyn